A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Stimulants
This training will cover the physiological and psychological symptoms of overamping, or psychostimulant overdose. Participants will gain knowledge on how to respond to overamping and the pharmacological interventions used to treat symptoms of overamping.
 |
Monday, 12/7/2026 3:00 pm – 4:00 pm ET |
 |
Virtual event |
 |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training is designed to provide foundational knowledge and skills in initiating buprenorphine treatment for opioid use disorder in the outpatient setting in the context of the widespread presence of illicitly manufactured fentanyl. We explore how the potency and prevalence of fentanyl complicates the initiation phase of buprenorphine treatment, leading to potential clinical challenges such as precipitated withdrawal. We suggest participating in the next training in the series, Buprenorphine 201, upon completing Buprenorphine 101.
|
Thursday, 12/10/2026 9:00 am – 10:00 am ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: Alcohol
This training is designed to provide an introductory overview of alcohol use disorders. We will explore the latest epidemiological data, with a focus on the prevalence and trends of alcohol use and alcohol use disorders in the United States. Diagnostic criteria and screening tools to assess for alcohol use disorders will be discussed. Additionally, we will examine evidence-based interventions to treat alcohol use disorders and support individuals in their recovery.
|
Friday, 12/11/2026 9:00 am – 10:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Kratom
This training aims to increase learners’ understanding of kratom prevalence, misuse patterns, and clinical management. The activity provides evidence-based content that enables healthcare providers to accurately characterize kratom use, recognize signs and symptoms of kratom intoxication and withdrawal, and understand associated health risks. Improved knowledge is expected to reduce under-recognition of kratom-related concerns and promote more informed, consistent, and patient-centered care across interprofessional practice settings.
|
Monday, 12/14/2026 8:00 am – 9:00 am ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Stimulants
This training is a guide for addiction care teams caring for people who use stimulants, including cocaine and methamphetamines. The training will review the basic science of addiction related to stimulants and discuss the practical implementation of evidence-based treatment for patients who use stimulants, with a concentration on outpatient treatment settings.
|
Tuesday, 12/15/2026 1:00 pm – 4:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Judith Austin, PMHNP, CARN-AP, will strengthen interdisciplinary collaboration in the assessment and treatment of psychiatric conditions among people with co-occurring substance use disorders, and identify common psychiatric disorders and clinical presentations encountered in people with substance use disorders. She will also apply evidence-informed principles for initiating, monitoring, and educating patients about commonly prescribed psychiatric medications in the context of substance use disorders. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
|
Wednesday, 12/16/2026 12:00 pm – 1:15 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Robert Lowe, MD, will improve interdisciplinary coordination in the identification and management of alcohol-related liver disease among patients with alcohol use disorder and recognize key risk factors, clinical features, and stages of alcohol-related liver disease relevant to addiction treatment settings. He will also apply evidence-informed strategies for screening, assessment, treatment, and referral for patients with alcohol-related liver disease. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
|
Wednesday, 1/6/2027 12:00 pm – 1:15 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training provides healthcare providers with advanced knowledge and practical skills to deliver high-quality, patient-centered treatment plans for individuals on buprenorphine for opioid use disorder (OUD). Participants will enhance their confidence in buprenorphine initiation through real-world case studies, exploring low-barrier models of care to improve access for individuals with OUD and strategies to reduce the risk of precipitated withdrawal.
|
Thursday, 1/14/2027 9:00 am – 11:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Julia Calandra, PharmD, BCACP, will develop interdisciplinary models of low-barrier hepatitis C care that improve coordination between addiction treatment, medical, and harm reduction services and describe principles of low-barrier, person-centered hepatitis C care and their role in reducing disparities among people who use substances. She will also apply practical strategies for integrating hepatitis C screening and treatment into addiction medicine and harm reduction settings, including models such as group care. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
|
Wednesday, 1/20/2027 12:00 pm – 1:15 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Judith Austin, PMHNP, CARN-AP, will strengthen interdisciplinary to evaluating and treating adults with suspected ADHD and co-occurring substance use disorders, and differentiate symptoms of ADHD from substance use, intoxication, withdrawal, and other psychiatric conditions with overlapping presentations. She will also apply evidence-informed strategies for assessing and diagnosing ADHD in adults with substance use disorders, including considerations for treatment planning and coordination of care. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
|
Wednesday, 2/3/2027 12:00 pm – 1:15 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.
© 2026 Boston Medical Center. All rights reserved. Site by Root802.